Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
暂无分享,去创建一个
P. Black | E. Buchdunger | J. Alberta | C. Stiles | T. O'reilly | M. Acar | P. Iannarelli | Peter McL. Black | T. Kilic | P. Zdunek | Turker Kilic | Pawel R. Zdunek
[1] Reuven Agami,et al. Interaction of c-Abl and p73α and their collaboration to induce apoptosis , 1999, Nature.
[2] Jijie Gu,et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.
[3] Antonio Costanzo,et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.
[4] M. Nistér,et al. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. , 1998, Cancer research.
[5] P. Black,et al. Detection of activated platelet-derived growth factor receptors in human meningioma. , 1997, Cancer research.
[6] J. Bruner,et al. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. , 1996, Neurosurgery.
[7] Jürg Zimmermann,et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.
[8] O. Potapova,et al. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. , 1996, Cancer research.
[9] D. Louis,et al. A tiger behind many doors: multiple genetic pathways to malignant glioma. , 1995, Trends in genetics : TIG.
[10] A. Guha,et al. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop , 1995, International journal of cancer.
[11] A. Ullrich,et al. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. , 1994, The Journal of biological chemistry.
[12] C. Heldin,et al. Activated platelet‐derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line , 1994, Journal of cellular physiology.
[13] S. Shamah,et al. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells , 1993, Molecular and cellular biology.
[14] C. Heldin,et al. Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant , 1993, Molecular and cellular biology.
[15] C. Heldin,et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. , 1992, Cancer research.
[16] A. van Koppen,et al. Is PDGF really important? Testing the hypotheses. , 1991, Trends in genetics : TIG.
[17] C. Heldin,et al. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. , 1991, The Journal of biological chemistry.
[18] P. Black,et al. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. , 1990, The Journal of clinical investigation.
[19] D Riddoch,et al. Neoplasms of the central nervous system. , 1977, The Practitioner.
[20] D. Louis,et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. , 1996, Cancer research.
[21] D. Louis,et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. , 1996, Cancer research.
[22] T. Meyer,et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. , 1996, Cancer research.
[23] C. Heldin,et al. Structure of platelet-derived growth factor: implications for functional properties. , 1993, Growth factors.